mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.1 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |